HER-3 reactive CD4 T cells recognized not only HLA-DR-matched tumor cell lysates but also DCs pulsed with HER-3-positive HLA-DR-unmatched tumor cell lysates (Fig. 5). The gene discussed is ERBB3; the disease is neoplasm.